Drug:
Reaction: DYSPNOEA
20250101 - 20251231
No. 201 - 300
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
201 | 25126764 |
GB |
60 | |
Dyspnoea, Brain injury, Asthma, |
||||
TEZEPELUMAB-EKKO, TIOTROPIUM BROMIDE, THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, AMLODIPINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
202 | 25126906 |
US |
48 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Product lot number issue, |
||||
ALBUTEROL SULFATE, |
||||
203 | 25127182 |
US |
||
Dyspnoea, Hypoaesthesia, Off label use, |
||||
MAVACAMTEN, |
||||
204 | 25127250 |
JP |
75 | 1 |
Cholecystitis, Pain, Diarrhoea, Dyspnoea, Nausea, Dysphonia, Dyspnoea, |
||||
NINTEDANIB, |
||||
205 | 25127265 |
GB |
2 | |
Respiratory failure, Dyspnoea, Influenza, Malignant neoplasm progression, Breast cancer metastatic, Anaemia, |
||||
FULVESTRANT, RIBOCICLIB, |
||||
206 | 25127272 |
CA |
63 | 2 |
Abdominal pain, Pruritus, Flushing, Dyspnoea, Hallucination, visual, Rash, Urticaria, |
||||
CISPLATIN, DIPHENHYDRAMINE HYDROCHLORIDE, APREPITANT, FOSAPREPITANT DIMEGLUMINE, MONTELUKAST, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, RANITIDINE, |
||||
207 | 25127324 |
US |
63 | 2 |
Dyspnoea, Defaecation urgency, Diarrhoea, |
||||
ABEMACICLIB, |
||||
208 | 25127329 |
CA |
68 | 2 |
Cough, Chest pain, Dyspnoea, Hypersensitivity, Flushing, |
||||
PACLITAXEL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, APIXABAN, EZETIMIBE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEVOTHYROXINE, OLANZAPINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, SENNOSIDES, |
||||
209 | 25127343 |
US |
12 | |
Dyspnoea, Discomfort, Drug dose omission by device, Wrong technique in product usage process, Device information output issue, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
210 | 25127350 |
CZ |
45 | 1 |
Nausea, Chills, Dyspnoea, Abdominal pain, Dizziness, Dizziness, Dizziness, Back pain, Headache, Arthralgia, Application site mass, Application site mass, Application site mass, Application site pain, Application site pain, Application site pain, |
||||
DUPILUMAB, |
||||
211 | 25127377 |
CA |
54 | 2 |
Chest pain, Dyspnoea, Flushing, Oxygen saturation decreased, |
||||
ETOPOSIDE, NETUPITANT AND PALONOSETRON, FOSNETUPITANT AND PALONOSETRON, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
212 | 25127525 |
CA |
62 | |
Malaise, Wheezing, Pulmonary function test abnormal, Lung adenocarcinoma stage IV, Seizure, Pneumothorax, Exercise tolerance decreased, Drug dependence, Loss of personal independence in daily activities, Full blood count abnormal, Dyspnoea, Chronic obstructive pulmonary disease, Chest discomfort, Bronchitis, Asthma, Therapeutic product effect incomplete, Bone pain, Craniotomy, Gait disturbance, Heart rate increased, Illness, Joint swelling, Metastases to central nervous system, Sleep disorder due to a general medical condition, Steroid dependence, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUDESONIDE, BUDESONIDE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, OXYGEN, 0XYGEN, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RISEDRONATE SODIUM, ALBUTEROL SULFATE, ERGOCALCIFEROL, ERGOCALCIFEROL, |
||||
213 | 25127548 |
CA |
65 | 2 |
Asthma, Chest pain, Cough, Drug hypersensitivity, Dyspnoea, Malaise, Oedema, Pain, Pneumonia, Respiratory tract infection, Vomiting, Wheezing, |
||||
OMALIZUMAB, RITUXIMAB, CLONAZEPAM, |
||||
214 | 25127549 |
JP |
48 | 2 |
Pancytopenia, Malignant neoplasm progression, Hypothyroidism, Oedema peripheral, Breast pain, Hepatic function abnormal, Tumour associated fever, Alopecia, Dyspnoea, Palmar-plantar erythrodysaesthesia syndrome, Dysphonia, Diarrhoea, Myalgia, |
||||
CABOZANTINIB, CABOZANTINIB, CABOZANTINIB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, IPILIMUMAB, IPILIMUMAB, |
||||
215 | 25127570 |
US |
63 | 2 |
Illness, Dyspnoea, Otorrhoea, Nausea, Respiratory tract congestion, Product dose omission issue, |
||||
MEPOLIZUMAB, LEVOTHYROXINE, AMLODIPINE BESYLATE, FAMOTIDINE, SEMAGLUTIDE, MONTELUKAST, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, CYCLOBENZAPRINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ZOLPIDEM TARTRATE, PREDNISONE, MECLIZINE HCL 12.5 MG, MECLIZINE, MECLIZINE HYDROCHLORIDE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, BUPROPION HYDROCHLORIDE, BUPROPION, AMOXICILLIN, |
||||
216 | 25127659 |
DE |
73 | 1 |
Chills, Dyspnoea, Chest pain, General physical health deterioration, Cough, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALLOPURINOL, DAPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANTOPRAZOLE, ROSUVASTATIN, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, RIVAROXABAN, |
||||
217 | 25127698 |
US |
||
Seizure, Respiratory tract infection, Dyspnoea, Headache, Asthenia, Neck pain, COVID-19, Influenza, Insomnia, Musculoskeletal stiffness, Fatigue, |
||||
RAVULIZUMAB, PYRIDOSTIGMINE BROMIDE, PYRIDOSTIGMINE BROMIDE, |
||||
218 | 25127778 |
US |
71 | |
Enterovirus infection, Rhinovirus infection, T-cell lymphoma, Cutaneous T-cell lymphoma, Bronchiectasis, Pulmonary mass, Drug ineffective, Dyspnoea, Chronic obstructive pulmonary disease, Upper respiratory tract infection, Nasal congestion, Wheezing, Cough, Therapeutic response delayed, Asthma, Secretion discharge, Sputum retention, |
||||
BENRALIZUMAB, DUPILUMAB, ROFLUMILAST, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, PREDNISONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ROFLUMILAST, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, MONTELUKAST, |
||||
219 | 25127807 |
GB |
56 | 2 |
Lower respiratory tract infection, Dysstasia, Feeding disorder, Oropharyngeal pain, Malaise, Hyperhidrosis, Pyrexia, Dyspnoea, Psoriasis, Axial spondyloarthritis, Condition aggravated, Toothache, Feeling abnormal, Influenza like illness, Cold sweat, Ageusia, Tonsillitis, Sinusitis, Hypoaesthesia, Musculoskeletal discomfort, Limb injury, Contusion, Injection site pain, Injection site pruritus, Injection site bruising, Anxiety, Migraine, Crying, Insomnia, Therapeutic product effect decreased, Viral infection, |
||||
ETANERCEPT, ETANERCEPT, METHOTREXATE SODIUM, |
||||
220 | 25127998 |
GB |
59 | |
Paraesthesia oral, Dyspnoea, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, ALBUTEROL, PERINDOPRIL ERBUMINE, |
||||
221 | 25128090 |
EG |
66 | 2 |
Hot flush, Dyspnoea, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
222 | 25128112 |
US |
75 | 1 |
Hypervolaemia, Oedema peripheral, Asthenia, Dizziness, Dyspnoea, Anxiety, Respiratory disorder, Panic attack, Hypoxia, Delirium, Deep vein thrombosis, Respiratory failure, Muscular weakness, |
||||
PREDNISONE, |
||||
223 | 25128174 |
CA |
74 | 2 |
Fluid retention, Intestinal obstruction, Dyspnoea, Skin ulcer, Drug ineffective, Device infusion issue, Intentional product use issue, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
224 | 25128180 |
US |
67 | |
Dyspnoea, Wheezing, Drug dose omission by device, Device deposit issue, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
225 | 25128186 |
US |
48 | |
Limb discomfort, Chest pain, Dyspnoea, Hypersensitivity, Increased appetite, |
||||
LIRAGLUTIDE, |
||||
226 | 25128198 |
BG |
42 | |
Blood pressure increased, Dyspnoea, Cough, Palpitations, Asthenia, Eye disorder, Peripheral swelling, Systolic dysfunction, Diastolic dysfunction, Cardiac disorder, Ventricular hypokinesia, Viral infection, Dizziness, Loss of consciousness, Mitral valve incompetence, Tricuspid valve incompetence, Pulmonary arterial hypertension, Cardiac aneurysm, Pericardial effusion, Pleural effusion, |
||||
DAPAGLIFLOZIN, GOSERELIN, GOSERELIN, DAPAGLIFLOZIN, |
||||
227 | 25128469 |
US |
19 | 1 |
Hospitalisation, Hypoxia, Pyrexia, Dyspnoea, Product use issue, |
||||
RIOCIGUAT, RIOCIGUAT, |
||||
228 | 25128483 |
US |
68 | |
Drug dose omission by device, Wrong technique in product usage process, Dyspnoea, Device deposit issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
229 | 25128544 |
IT |
57 | 1 |
Disease progression, Therapeutic product effect incomplete, Paraesthesia, Asthenia, Dyspnoea, Cough, Wheezing, |
||||
CARBOPLATIN, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PACLITAXEL, |
||||
230 | 25128737 |
US |
52 | 2 |
Dyspnoea, Sinus congestion, |
||||
DUPILUMAB, DUPILUMAB, |
||||
231 | 25128931 |
US |
56 | 2 |
Abdominal discomfort, Dyspnoea, Pyrexia, Hyperhidrosis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
232 | 25129021 |
US |
55 | |
Dyspnoea, Drug dose omission by device, Device delivery system issue, Panic reaction, Off label use, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
233 | 25129105 |
US |
1 | |
Dyspnoea, Syncope, |
||||
234 | 25129151 |
US |
1 | |
Dyspnoea, Ill-defined disorder, Overdose, Product dose omission issue, |
||||
FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
235 | 25129170 |
US |
||
Chest pain, Syncope, Dyspnoea, Fall, Nerve compression, Chronic obstructive pulmonary disease, Lung disorder, Tooth disorder, |
||||
236 | 25129278 |
GB |
||
Respiratory failure, Dyspnoea, Influenza, Malignant neoplasm progression, Breast cancer metastatic, Anaemia, |
||||
FULVESTRANT, FULVESTRANT, RIBOCICLIB, |
||||
237 | 25129288 |
US |
74 | 2 |
Dyspnoea, Nasopharyngitis, Cough, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Asthma, Drug ineffective, |
||||
DUPILUMAB, TIOTROPIUM BROMIDE INHALATION SPRAY, ROPINIROLE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, ALENDRONATE SODIUM, MELOXICAM, AMLODIPINE BESYLATE, LEVOTHYROXINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, LETROZOLE, LETROZOLE TABLETS, MONTELUKAST, CETIRIZINE HCL, CETIRIZINE, AZELASTINE, ALBUTEROL SULFATE, |
||||
238 | 25129355 |
ZA |
42 | 2 |
Skin burning sensation, Flushing, Rash macular, Pruritus, Dyspnoea, Urticaria, Product prescribing error, |
||||
DEXLANSOPRAZOLE, |
||||
239 | 25129370 |
US |
44 | 2 |
Drug hypersensitivity, Urticaria, Swelling face, Dyspnoea, Chest pain, Vomiting, Vision blurred, Anaphylactic reaction, Exposure during pregnancy, |
||||
INSULIN LISPRO, INSULIN LISPRO, FAMOTIDINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INSULIN ASPART, INSULIN ASPART, INSULIN ASPART, EPINEPHRINE, ADRENALINUM, OMALIZUMAB, OMALIZUMAB, INSULIN DEGLUDEC, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
240 | 25129376 |
US |
44 | 2 |
Dyspnoea, Hypersensitivity, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
241 | 25129435 |
US |
2 | |
Dyspnoea, |
||||
DEUCRAVACITINIB, |
||||
242 | 25129538 |
US |
58 | 2 |
Skin disorder, Fatigue, Dyspnoea, Inappropriate schedule of product administration, |
||||
BELUMOSUDIL, ALBUTEROL SULFATE, DEXLANSOPRAZOLE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FLUTICASONE PROPIONATE, TRIPROLIDINE HCL, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, GABAPENTIN, HYDROCHLOROTHIAZIDE, LORAZEPAM, LOTEPREDNOL ETABONATE, MONTELUKAST, PREDNISONE, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
243 | 25129837 |
US |
68 | 2 |
Hypoaesthesia, Asthma, Dyspnoea, Polyp, Condition aggravated, Arthralgia, Injection site swelling, |
||||
DUPILUMAB, |
||||
244 | 25129843 |
CN |
64 | 1 |
Hyperpyrexia, Chills, Dyspnoea, |
||||
OBINUTUZUMAB, |
||||
245 | 25129854 |
CA |
24 | 2 |
Swelling face, Fatigue, Throat irritation, Limb discomfort, Dysphemia, Dyspnoea, Paraesthesia, |
||||
FERRIC DERISOMALTOSE, |
||||
246 | 25129867 |
CA |
71 | 2 |
Asthma, Dyspnoea, Impaired quality of life, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Wheezing, Drug ineffective, |
||||
CICLESONIDE, MEPOLIZUMAB, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
247 | 25129888 |
US |
73 | |
Cataract, Blood thyroid stimulating hormone increased, Nasal dryness, Bursitis, Dry mouth, Dyspnoea, Dry eye, Dry throat, |
||||
THYROID, PORCINE, ATORVASTATIN CALCIUM, RAMIPRIL, |
||||
248 | 25129902 |
US |
61 | 1 |
Diarrhoea, Balance disorder, Dyspnoea, Pain, Myocardial infarction, |
||||
POMALIDOMIDE, POMALIDOMIDE, DARATUMUMAB, DARATUMUMAB, |
||||
249 | 25130018 |
AU |
50 | 2 |
Hypokalaemia, Wheezing, Dyspnoea, Neutropenia, Cough, Decreased appetite, Musculoskeletal chest pain, Oropharyngeal pain, Constipation, Headache, Oxygen saturation decreased, |
||||
ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, DOCUSATE SODIUM,SENNOSIDES, FENOFIBRATE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, ALBUTEROL SULFATE, ALBUTEROL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ALBUTEROL SULFATE, OXYCODONE, CELECOXIB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREGABALIN, ALBUTEROL SULFATE, CICLESONIDE, CLOZAPINE, CHOLESTYRAMINE, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, FLUTICASONE PROPIONATE, |
||||
250 | 25130061 |
US |
80 | 2 |
Infection, Dyspnoea, Lung disorder, |
||||
DUPILUMAB, DUPILUMAB, |
||||
251 | 25130105 |
US |
37 | 2 |
Injection site pruritus, Injection site pain, Asthma, Dyspnoea, Therapeutic response shortened, Off label use, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
252 | 25130428 |
IT |
81 | 1 |
Gastrointestinal toxicity, Dyspnoea, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LINAGLIPTIN, CHLORPHENIRAMINE MALEATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
253 | 25130478 |
69 | ||
Somnolence, Dyspnoea, Brain fog, Anaemia, Off label use, |
||||
RUXOLITINIB, |
||||
254 | 25130581 |
DE |
2 | |
Epstein-Barr virus infection, Abdominal pain, Splenomegaly, Haematoma, Splenic rupture, Dyspnoea, Blood disorder, Fatigue, Pain, |
||||
ERENUMAB-AOOE, |
||||
255 | 25130702 |
ZA |
83 | |
Obstruction, Cardiac failure, Dyspnoea, Hypotension, |
||||
DAPAGLIFLOZIN, FUROSEMIDE, DOXAZOSIN MESYLATE, LEVOTHYROXINE, NITROFURANTOIN MACROCRYSTALS, |
||||
256 | 25130724 |
FR |
53 | 2 |
Feeling abnormal, Retinal vein occlusion, Anaemia, Road traffic accident, Fall, Craniocerebral injury, Vertigo, Cervical vertebral fracture, Back disorder, Hand dermatitis, Deafness, Dyspnoea, Fatigue, Dizziness, Chest pain, Influenza, Fear of falling, Tachycardia, Pain in extremity, Fear, Polyuria, Mouth ulceration, Dry mouth, Lip injury, Serum ferritin decreased, Eczema, Drug ineffective, Drug intolerance, Inappropriate schedule of product administration, |
||||
SPIRONOLACTONE, |
||||
257 | 25130744 |
US |
||
Stress cardiomyopathy, Hypotension, Ejection fraction decreased, Blood pressure systolic decreased, Hypoxia, Dyspnoea, Mental status changes, Hyperhidrosis, Erythema, Flushing, Circumoral swelling, Oedema peripheral, Acute kidney injury, Hypertransaminasaemia, Pulmonary oedema, Troponin increased, Lactic acidosis, Overdose, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, TETRACAINE, |
||||
258 | 25130763 |
US |
6 | 2 |
Chest pain, Dyspnoea, |
||||
VALBENAZINE, |
||||
259 | 25130773 |
CA |
||
Addison^s disease, Asthma, Dyspnoea, Infection, Loss of personal independence in daily activities, Productive cough, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, Wheezing, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MEPOLIZUMAB, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ERGOCALCIFEROL, LORAZEPAM, MENADIONE, PREDNISONE, PREDNISONE, TIOTROPIUM BROMIDE, TOBRAMYCIN SULFATE, CEFTAZIDIME, METHYLPREDNISOLONE, PANCRELIPASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
260 | 25130783 |
US |
1 | |
Dizziness postural, Erythema, Swelling face, Brain fog, Headache, Dyspnoea, |
||||
LECANEMAB, |
||||
261 | 25130787 |
CA |
||
Psoriasis, Pruritus, Contusion, Subcutaneous drug absorption impaired, Confusional state, Infusion related reaction, Blood cholesterol increased, Abdominal discomfort, Back disorder, Peripheral swelling, Depression, Glossodynia, Musculoskeletal stiffness, Folliculitis, Pyrexia, Muscle injury, Chest pain, Pustular psoriasis, Adjustment disorder with depressed mood, Oedema, Duodenal ulcer perforation, Injury, Myositis, Malaise, Fibromyalgia, Joint swelling, Gait disturbance, Pulmonary fibrosis, Impaired healing, Blister, Dislocation of vertebra, Gait inability, Fatigue, Anti-cyclic citrullinated peptide antibody positive, Breast cancer stage II, Amnesia, Mobility decreased, Rheumatoid arthritis, Lower respiratory tract infection, Sleep disorder, Delirium, Systemic lupus erythematosus, Rheumatoid factor positive, General symptom, Weight increased, Decreased appetite, Hypoaesthesia, Pneumonia, Abdominal pain upper, Sleep disorder due to general medical condition, insomnia type, Swollen joint count increased, Joint range of motion decreased, Hand deformity, Grip strength decreased, Swelling, X-ray abnormal, Dyspepsia, Weight decreased, Type 2 diabetes mellitus, Disability, Hepatic enzyme increased, Pemphigus, Condition aggravated, Dyspnoea, Urticaria, Hypertension, Gastrointestinal disorder, Wound, Arthropathy, Liver injury, Stomatitis, Fluid retention, Arthralgia, Hypercholesterolaemia, Discomfort, Migraine, General physical health deterioration, Ill-defined disorder, Psoriatic arthropathy, Wheezing, Pain in extremity, Rheumatic fever, Memory impairment, Rash vesicular, Alopecia, Nasopharyngitis, Diarrhoea, Nausea, Wound infection, Vomiting, Headache, Hypersensitivity, Helicobacter infection, Infection, Irritable bowel syndrome, Synovitis, Sinusitis, Pericarditis, Pain, Rash, Drug hypersensitivity, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ALENDRONATE SODIUM, CALCIUM CARBONATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ETANERCEPT, ETANERCEPT, ETANERCEPT, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, FOLIC ACID, FOLIC ACID, FOLIC ACID, VEDOLIZUMAB, CERTOLIZUMAB PEGOL, ADALIMUMAB, NAPROXEN, NAPROXEN SODIUM, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, INFLIXIMAB, INFLIXIMAB, ADALIMUMAB, GOLIMUMAB, PHENYLEPHRINE HYDROCHLORIDE, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, USTEKINUMAB, GOLIMUMAB, OXYCODONE HYDROCHLORIDE, OXYCODONE, FOLIC ACID, FOLIC ACID, FOLIC ACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, VITAMIN C, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, PREDNISONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, APREMILAST, RITUXIMAB, LORAZEPAM, CAFFEINE CITRATE, CALCIUM GLUCONATE, SECUKINUMAB, SECUKINUMAB, ERGOCALCIFEROL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, LISINOPRIL, LORAZEPAM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, SULFASALAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
262 | 25130954 |
CN |
82 | 2 |
Contrast media allergy, Fatigue, Dizziness, Flushing, Cough, Dyspnoea, Rash maculo-papular, Anaphylactic shock, Hypotension, |
||||
IOPROMIDE, IOPROMIDE, |
||||
263 | 25130980 |
NL |
2 | |
Respiratory tract infection, Drug ineffective, Eczema, Drug hypersensitivity, Asthma, Nausea, Erythema, Stridor, Dyspnoea, Tachypnoea, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, METHYLPREDNISOLONE, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
264 | 25131037 |
CA |
33 | 2 |
Abdominal pain, Alopecia, Anorectal disorder, Anxiety, Arthralgia, Attention deficit hyperactivity disorder, Brain fog, Breast pain, Burning sensation, Chills, Cognitive disorder, Drug ineffective, Drug interaction, Dyspepsia, Dysphagia, Dyspnoea, Gastrointestinal pain, Haemorrhage, Headache, Hepatic pain, Hyperhidrosis, Joint swelling, Pain, Paraesthesia, Peripheral swelling, Photosensitivity reaction, Product availability issue, Product formulation issue, Product physical issue, Product shape issue, Product size issue, Product substitution issue, Suspected product tampering, Product taste abnormal, Rash, Rash erythematous, Swelling, Temperature regulation disorder, Therapy interrupted, Tremor, Urinary tract pain, Vaginal disorder, Withdrawal syndrome, |
||||
NIRMATRELVIR AND RITONAVIR, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMITRIPTYLINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, |
||||
265 | 25131060 |
PL |
67 | 1 |
Pulmonary embolism, Fatigue, Asthenia, Anxiety, Dyspnoea, |
||||
CISPLATIN, PEMETREXED, PEMETREXED DISODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
266 | 25131195 |
CA |
87 | 1 |
Pneumonia aspiration, Dyspnoea, Multiple organ dysfunction syndrome, Bacterial test positive, Rheumatoid arthritis, Arthralgia, Joint swelling, Muscular weakness, |
||||
SARILUMAB, |
||||
267 | 25131226 |
JP |
57 | 1 |
Haematochezia, Colitis ulcerative, Palpitations, Dyspnoea, Nausea, |
||||
MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, MESALAMINE, AZATHIOPRINE, AZATHIOPRINE, |
||||
268 | 25131259 |
GB |
2 | |
Hepatic cancer, Dyspnoea, Heart rate irregular, Confusional state, Decreased appetite, Contusion, Joint swelling, Peripheral swelling, Feeling cold, Pallor, Back pain, Abdominal pain upper, Dizziness, Nausea, Fatigue, Pruritus, Weight decreased, Headache, |
||||
LANREOTIDE ACETATE, |
||||
269 | 25131446 |
US |
||
Dyspnoea, Paranasal sinus hypersecretion, |
||||
VIGABATRIN, VIGABATRIN, VIGABATRIN, |
||||
270 | 25131616 |
AT |
1 | |
Anaphylactic reaction, Choking, Drug intolerance, Dyspnoea, Claustrophobia, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
271 | 25131690 |
US |
||
Visual impairment, Follicular lymphoma, Cough, Dyspnoea, Gastrooesophageal reflux disease, Lymphadenopathy, |
||||
PEGCETACOPLAN, PEGCETACOPLAN, AFLIBERCEPT, |
||||
272 | 25131701 |
MT |
64 | 2 |
Palpitations, Hypertension, Dyspnoea, Dysgeusia, Rash, |
||||
ANASTROZOLE, ERGOCALCIFEROL, AMLODIPINE, |
||||
273 | 25131818 |
US |
47 | |
Nephrolithiasis, Systemic lupus erythematosus, Cardiomyopathy, Sjogren^s syndrome, Enchondromatosis, Muscle hypertrophy, Hyperparathyroidism, Pleurisy, Ketonuria, Nausea, Bronchospasm, Myalgia, Lymphadenopathy, Rhinorrhoea, Upper-airway cough syndrome, Temporomandibular pain and dysfunction syndrome, Nasal ulcer, Nasal crusting, Tinnitus, Dysphonia, Dysphagia, Rash, Skin lesion, Skin hypopigmentation, Livedo reticularis, Pruritus, Increased tendency to bruise, Alopecia, Palpitations, Photosensitivity reaction, Varicose vein, Skin discolouration, Temperature intolerance, Foreign body sensation in eyes, Chest pain, Chest discomfort, Oedema, Abdominal pain, Abdominal distension, Dyspnoea, Dyspnoea exertional, Dysuria, Dyspareunia, Nocturia, Muscle spasms, Joint range of motion decreased, Back pain, Muscle swelling, Bone pain, Muscular weakness, Balance disorder, Dizziness, Hypoaesthesia, Paraesthesia, Joint noise, Tendonitis, Pulmonary mass, Sleep disorder, Migraine, Vitamin B12 deficiency, Multiple allergies, Intervertebral disc disorder, Raynaud^s phenomenon, Joint swelling, Joint stiffness, Synovitis, Grip strength decreased, |
||||
ANIFROLUMAB-FNIA, DENOSUMAB, DENOSUMAB, DENOSUMAB, PREDNISONE, BELIMUMAB, ETANERCEPT, APREMILAST, DIPHENHYDRAMINE HYDROCHLORIDE, TEMAZEPAM, NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE, PANTOPRAZOLE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, ERGOCALCIFEROL, FAMCICLOVIR, SPIRONOLACTONE, ALBUTEROL SULFATE, PHENTERMINE HYDROCHLORIDE, RIMEGEPANT SULFATE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, MELOXICAM, MELATONIN, MODAFINIL, KETOROLAC TROMETHAMINE, BACLOFEN, MONTELUKAST, ESTRADIOL, TIZANIDINE, METHOCARBAMOL, SOLRIAMFETOL, ZAFIRLUKAST, LEMBOREXANT, PANTOPRAZOLE SODIUM, UBROGEPANT, COLCHICINE, DARIDOREXANT, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, LEFLUNOMIDE, |
||||
274 | 25131860 |
US |
||
Hypoxia, Arrhythmia, Abdominal pain, Anaemia, Pleural effusion, Hypotension, Dizziness, Dyspnoea, Microcytic anaemia, Gastrooesophageal reflux disease, Haemorrhage, |
||||
SELEXIPAG, SELEXIPAG, SILDENAFIL CITRATE, SILDENAFIL, SILDENAFIL POWDER,, AMBRISENTAN, CEPHALEXIN, TRIMETHOPRIM, WARFARIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
275 | 25131870 |
US |
70 | 2 |
COVID-19, Swollen tongue, Muscular weakness, Skin haemorrhage, Joint swelling, Blister rupture, Peripheral swelling, Heart rate irregular, Gait disturbance, Muscle spasms, Skin discolouration, Blister, Rash vesicular, Dizziness, Headache, Arthralgia, Somnolence, Paraesthesia, Rash, Myalgia, Dyspnoea, |
||||
LOSARTAN POTASSIUM, LOSARTAN, CLONIDINE HYDROCHLORIDE, CLONIDINE, LEVOTHYROXINE SODIUM, |
||||
276 | 25132022 |
US |
2 | |
Cough, Dyspnoea exertional, Headache, Bendopnoea, Fatigue, Abdominal pain upper, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, NINTEDANIB, AMBRISENTAN, OXYGEN, 0XYGEN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
277 | 25134491 |
20 | 1 | |
Drooling, Gait disturbance, Gait inability, Dysphagia, Dyspnoea, Unresponsive to stimuli, Swelling face, Flushing, Erythema, Rash, Musculoskeletal stiffness, Hypersensitivity, Confusional state, Muscle rigidity, Feeding disorder, Grip strength decreased, Neuroleptic malignant syndrome, |
||||
RISPERIDONE, CHLORPROMAZINE, DIVALPROEX SODIUM, |
||||
278 | 25134661 |
60 | 1 | |
Oxygen saturation decreased, Dyspnoea, |
||||
AMBRISENTAN, TADALAFIL, |
||||
279 | 25120957 |
US |
||
Dyspnoea, Product dose omission issue, Illness, Tremor, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
280 | 25121051 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Blood cholesterol increased, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Drug hypersensitivity, Drug intolerance, Drug-induced liver injury, Dyspepsia, Dyspnoea, Fatigue, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Onychomadesis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, Prescribed overdose, Off label use, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, APREMILAST, APREMILAST, APREMILAST, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE, ATOMOXETINE, AZATHIOPRINE SODIUM, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE ACETATE, MINOCYCLINE, MINOCYCLINE, MINOCYCLINE HYDROCHLORIDE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PHENYLEPHRINE HYDROCHLORIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, RAMIPRIL, RAMIPRIL, RAMIPRIL, RANITIDINE, RANITIDINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, THIAMINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TRAMADOL HYDROCHLORIDE, VITAMIN A, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
281 | 25121062 |
US |
2 | |
Cough, Asthenia, Blood pressure abnormal, Dyspnoea, Muscular weakness, Gait disturbance, Productive cough, Dizziness, Headache, Nausea, Back pain, Abdominal pain upper, Constipation, Dyspnoea exertional, Muscle spasms, Brain fog, Irritability, Balance disorder, Memory impairment, Myalgia, Immunoglobulins increased, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 3350, |
||||
282 | 25121075 |
US |
2 | |
Blood pressure increased, Heart rate increased, Cough, Seasonal allergy, Chest pain, Dyspnoea, |
||||
TREPROSTINIL, TREPROSTINIL, HYDROXYCHLOROQUINE SULFATE, BELIMUMAB, ERGOCALCIFEROL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, OXYGEN, 0XYGEN, |
||||
283 | 25121121 |
CA |
1 | |
Asthma, Dyspnoea, Full blood count abnormal, Loss of personal independence in daily activities, Sleep disorder due to a general medical condition, Wheezing, Therapeutic product effect incomplete, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ACLIDINIUM BROMIDE, MEPOLIZUMAB, |
||||
284 | 25121152 |
US |
36 | 2 |
Abdominal pain upper, Dyspnoea, Pyrexia, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, POLYETHYLENE GLYCOL 3350, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, |
||||
285 | 25121193 |
US |
50 | 1 |
Nasal polyps, Rebound effect, Dyspnoea, Anosmia, |
||||
DUPILUMAB, DUPILUMAB, |
||||
286 | 25121237 |
US |
58 | 2 |
Dyspnoea, Illness, |
||||
DUPILUMAB, |
||||
287 | 25121264 |
CN |
51 | |
Interstitial lung disease, Dyspnoea, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
288 | 25121299 |
CN |
55 | |
Chest discomfort, Dyspnoea, Immune-mediated lung disease, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
289 | 25121323 |
CA |
67 | 1 |
Dyspnoea, Loss of consciousness, Taste disorder, |
||||
ALBUTEROL SULFATE, ALBUTEROL, |
||||
290 | 25121468 |
US |
84 | 1 |
Dyspnoea, |
||||
DUPILUMAB, |
||||
291 | 25121483 |
CA |
54 | 2 |
Cardiac failure congestive, Dyspnoea, Headache, Migraine, Pain, Skin cancer, Off label use, |
||||
ERENUMAB-AOOE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, NITROGLYCERIN, CLONAZEPAM, MIRABEGRON, LEVOTHYROXINE SODIUM, TOPIRAMATE, TOPIRAMATE SPINKLE, ESTRADIOL VALERATE, PROPRANOLOL HYDROCHLORIDE, GABAPENTIN, |
||||
292 | 25121489 |
US |
||
Dyspnoea, Fatigue, Decreased activity, Device issue, Product dose omission issue, Incorrect dose administered by device, Device delivery system issue, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
293 | 25121540 |
US |
52 | 1 |
Eye swelling, Ocular hyperaemia, Dyspnoea, Drug delivery system malfunction, Product administration interrupted, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, MACITENTAN, DIGOXIN, TADALAFIL, FUROSEMIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, |
||||
294 | 25121635 |
BG |
||
Pleural effusion, Pericardial effusion, Tricuspid valve incompetence, Cardiac aneurysm, Ventricular hypokinesia, Pulmonary arterial hypertension, Eye disorder, Mitral valve incompetence, Peripheral swelling, Loss of consciousness, Palpitations, Systolic dysfunction, Diastolic dysfunction, Cardiac disorder, Viral infection, Dizziness, Blood pressure increased, Dyspnoea, Asthenia, Cough, |
||||
GOSERELIN, GOSERELIN, DAPAGLIFLOZIN, GOSERELIN, DAPAGLIFLOZIN, |
||||
295 | 25121732 |
CA |
71 | |
Dizziness, Abdominal discomfort, Abdominal distension, Asthma, Dyspnoea, Dyspnoea exertional, Fatigue, Sleep apnoea syndrome, Loss of personal independence in daily activities, Product dose omission issue, Hospitalisation, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, |
||||
296 | 25121745 |
US |
30 | 1 |
Urticaria, Throat irritation, Dyspnoea, Chest discomfort, |
||||
ACETAMINOPHEN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
297 | 25121771 |
GB |
70 | 1 |
Bradycardia, Fatigue, Dyspnoea, Arrhythmia, Gastrooesophageal reflux disease, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
298 | 25121819 |
US |
51 | 1 |
Hiccups, Dyspnoea, |
||||
SEMAGLUTIDE, SEMAGLUTIDE, SEMAGLUTIDE, |
||||
299 | 25121825 |
JP |
66 | 1 |
Idiopathic pulmonary fibrosis, Gait inability, Dyspnoea, Food aversion, Diarrhoea, Taste disorder, Toothache, Mastication disorder, Tooth disorder, Faeces hard, Diarrhoea, Cough, Nasopharyngitis, Weight decreased, Decreased appetite, |
||||
NINTEDANIB, NINTEDANIB, |
||||
300 | 25121840 |
CA |
54 | 2 |
Skin cancer, Cardiac failure congestive, Migraine, Dyspnoea, Pain, Headache, Off label use, |
||||
ERENUMAB-AOOE, CLONAZEPAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MIRABEGRON, NITROGLYCERIN, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, TOPIRAMATE, TOPIRAMATE SPINKLE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ESTRADIOL VALERATE, GABAPENTIN, PROPRANOLOL HYDROCHLORIDE, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28